# Milk-derived Gangliosides for Inflammatory Bowel Disease

> **NCT02139709** · PHASE1 · WITHDRAWN · sponsor: **University of Alberta**

## Conditions studied

- Inflammatory Bowel Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Ganglioside
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT02139709
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-01
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** REB Approval expired.
- **Last updated:** 2022-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02139709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02139709, "Milk-derived Gangliosides for Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02139709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*